Institut National de la Sante et de la Rescherche Medicale (INSERM)
Patent Applications and Registrations
Patent applications and USPTO patent grants for Institut National de la Sante et de la Rescherche Medicale (INSERM).The latest application filed is for "identification of a jak2 mutation in polycythemia vera".
- Institut National de la Sante et de la Rescherche Medicale (INSERM) - Paris N/A FR
- Institut National de la Sante et de la Rescherche Medicale (Inserm) - Inserm
| Patent | Date |
|---|---|
| Identification of a JAK2 mutation in Polycythemia Vera Grant 10,563,200 - Vainchenker , et al. Feb | 2020-02-18 |
| Identification of a JAK2 Mutation in Polycythemia Vera App 20190323007 - VAINCHENKER; William ; et al. | 2019-10-24 |
| Use of gluclose-6-phosphate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds Grant 7,033,745 - Benoist , et al. April 25, 2 | 2006-04-25 |
| LTA4 hydrolase inhibitors Grant 6,878,723 - Danvy , et al. April 12, 2 | 2005-04-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 